SCHEMBL3586185

SCHEMBL3586185

CNc1ccc(Cl)cc1C(=O)N(CCc1cccc(C(F)(F)F)c1)Cc1ccc(C(F)(F)C(F)(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
KMT2A Q03164 2/20 0.40
CNR1 P21554 1/20 0.40
CYP2C9 P11712 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSPH1 Q92598 1/20 0.40
MPO P05164 1/20 0.40
C5AR1 P21730 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
SNCA P37840 1/20 0.38
SLC2A1 P11166 1/20 0.38
LPAR1 Q92633 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3575609 0.92 LMNA (0.43) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3583512 0.91 LMNA (0.41) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3584461 0.91 LMNA (0.44) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3573413 0.91 LMNA (0.44) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3585679 0.91 LMNA (0.44) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3571491 0.90 C5AR1 (0.42) LMNAC5AR1LPAR1LPAR5GAA
SCHEMBL3579622 0.90 CETP (0.43) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3576429 0.89 LPAR1 (0.43) LMNAMEN1KMT2ACNR1SMN1; SMN2
SCHEMBL3586145 0.88 CNR1 (0.42) CNR1ATMC5AR1SLC2A1LPAR1
SCHEMBL3573789 0.88 LMNA (0.41) LMNAHPGDMEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
EP-1984340-B1 ANTHRANILAMIDE/2-AMINO-HETEROARENE CARBOXAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-06-27 EP disclosed